Observational study of patients under anticoagulation therapy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00028689

Enrollment

Registered

2022-03-30

Start date

2022-03-06

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 Coagulopathy D69.59

Interventions

Group 1: Blood will be collected from every patients two times a day within the clinical routine to analyse the following laboratory parameters: aPTT, dTT and CT in ECA-test or IN/HI-test (ClotPro) an

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Intravenous anticoagulation therapy with argatroban.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Correlation between laboratory parameters and plasma values analyzed using pearson or spearman correlation.	—

Countries

Germany

Contacts

Public ContactLars Heubner

Universitätsklinikum Carl Gustav CarusKlinik und Poliklinik für Anästhesie und Intensivtherapie

lars.heubner@ukdd.de035145811660

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 26, 2026